MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?
Regenxbio Inc is a biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
414.7M
P/E Ratio
N/A
Total Cash
267.87M
Projected Growth
N/A
Total Debt
79.85M
Revenue
156.72M
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash/Share
5.32
Total Debt/Equity
N/A
Revenue/Share
3.08 USD as % of share price
Fundamentals
RGNX
Capitalization
415M
P/E Ratio
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash
268M
Total Cash/Share
5.32
Total Debt
79.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.08%
Revenue
157M
ROE
N/A
Book Value
274M
P/B Ratio
1.51
Cash Flow
N/A
Earnings
-3.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.93
Current Revenue Per Employee
252158.64
Dividends Per Share - Security
N/A
EBITDA
-122.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.14
Revenue To Assets
-28.16
Shares Held By Institutions
437M
Shares Outstanding - Current
50.4M
Total Liabilities
217M
Total Volume MTD
N/A
Value
-1
Gain YTD
6.468
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGNX showed earnings on May 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of gene therapy treatments
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com